Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2023-11-17 Regulatory Filings
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 100% confidence The document is a letter addressed to stock exchanges regarding the submission of a warning letter issued by the Securities and Exchange Board of India (SEBI) to the company's Compliance Officer. It references SEBI regulations and details the nature of the warning, the date of receipt, and the alleged violation. The document is short (3420 characters) and serves as an official regulatory announcement about a compliance issue, not a financial report or detailed audit. It does not contain financial data, management discussion, or report content but is a regulatory disclosure as required under SEBI Listing Regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2023-11-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings call held on November 2, 2023, for the quarter ended September 30, 2023. It includes detailed discussions by company executives about financial results, business segments, market conditions, and future outlook. The text explicitly states it is a transcript of the earnings call and contains Q&A sections. This matches the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full text of the call, not just an announcement or summary. Therefore, the correct classification is CT with high confidence.
2023-11-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the availability of the audio recording of the earnings conference call for the quarter ended September 30, 2023. It references the earnings call and provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document length is short (1457 characters) and serves as an announcement of the availability of the earnings call recording. According to the classification rules, such announcements about earnings calls are best classified as Call Transcript (CT) if the full transcript is provided, but since this is only an announcement of the audio recording availability, it is not the transcript itself. However, given the options, the closest and most appropriate classification is Call Transcript (CT) because it relates directly to the earnings call content, and no other category fits better. Confidence is high due to clear mention of earnings call and audio recording.
2023-11-02 English
Press Release
Earnings Release Classification · 95% confidence The document is titled as an "Earnings Press Release on the Results of the Company for the quarter ended September 30, 2023." It contains detailed financial highlights such as revenue, EBITDA, and PAT for Q2 FY24, along with segment-wise revenue performance and management commentary on the results. The document is approximately 9,585 characters long, which is substantial and contains actual financial data and analysis for the quarter. It is not merely an announcement of a report or a certification. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights.
2023-11-02 English
Investor Presentation
Regulatory Filings
2023-11-02 English
Acquisition
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement dated November 2, 2023, from Hikal Limited regarding the outcome of a Board Meeting. It includes approval of unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2023, along with a Limited Review Report from the statutory auditors. The document also contains detailed financial statements, notes, and auditor's review report, which are substantive financial data and analysis for a period shorter than a full fiscal year. Additionally, it includes information about a proposed acquisition, but the primary focus is on the unaudited financial results and the auditor's review. The presence of the Limited Review Report and detailed financial data for the quarter and half year period clearly identifies this as an Interim / Quarterly Report (IR). The document length (15,000 characters) and content confirm it is the report itself, not merely an announcement or certification. Therefore, the correct classification is IR with high confidence.
2023-11-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.